UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
____________________________________________________________
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
___________________________________________________________________
Date of Report (Date of earliest event
reported): March 16,
2009
XCORPOREAL, INC.
(Exact Name of Registrant as Specified
in Charter)
|
Delaware
|
001-33874
|
75-2242792
|
|
(State or other jurisdiction
of
incorporation)
|
(Commission File
Number)
|
(IRS Employer Identification
No.)
|
12121 Wilshire Blvd., Suite 350, Los
Angeles, California 90025
(Address of principal executive offices)
(Zip Code)
(310) 923-9990
(Registrant's telephone number,
including area code)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o Written communications pursuant to Rule
425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications
pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 8.01 Other
Events.
On March 16, 2009, Xcorporeal, Inc.
(the “Company”) issued a press release announcing an update on its current
operations and its exploration of various strategic alternatives. The press
release is attached hereto as Exhibit 99.1 and is incorporated herein
by this reference.
In
accordance with General Instruction B.6 of Form 8-K, the information in this report
will not be deemed
an admission as to
the materiality of any information in the report that is required to be
disclosed solely by Regulation FD. Unless
otherwise required by law, the Company disclaims any obligation to release
publicly any updates or any changes in its expectations or any change in events,
conditions, or circumstances on which any forward-looking statements are
based.
Item
9.01 Financial Statements and
Exhibits.
(d) Exhibits
Exhibit
No. Description
|
99.1
|
Press
release dated March 16, 2009
|
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.
|
|
XCORPOREAL,
INC.
|
|
|
|
|
|
Date: March 16,
2009
|
By:
|
/s/ Robert
Weinstein
|
|
|
|
Robert
Weinstein
|
|
|
|
Chief Financial
Officer
|